| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly | 1.74e-05 | 9 | 124 | 3 | GO:0000915 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in cytokinesis | 1.74e-05 | 9 | 124 | 3 | GO:0000912 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring organization | 2.47e-05 | 10 | 124 | 3 | GO:0044837 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly | 1.07e-04 | 3 | 124 | 2 | GO:1903475 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly actin filament organization | 1.07e-04 | 3 | 124 | 2 | GO:1903479 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in mitotic cytokinesis | 1.07e-04 | 3 | 124 | 2 | GO:1902407 | |
| GeneOntologyBiologicalProcess | embryo development | SOX5 COL12A1 HIPK1 SPEG MBNL1 INTS1 RDH10 TNRC6C CITED2 NCOR2 FOXP4 PEF1 MRTFB TP63 NUP133 NCOA1 KMT2A FLRT3 GNAS UTY EP300 | 1.27e-04 | 1437 | 124 | 21 | GO:0009790 |
| GeneOntologyCellularComponent | sperm end piece | 1.06e-04 | 3 | 125 | 2 | GO:0097229 | |
| Domain | Spectrin_repeat | 3.87e-05 | 29 | 124 | 4 | IPR002017 | |
| Domain | CSTF2_hinge | 4.37e-05 | 2 | 124 | 2 | PF14327 | |
| Domain | CSTF_C | 4.37e-05 | 2 | 124 | 2 | PF14304 | |
| Domain | CSTF2_hinge | 4.37e-05 | 2 | 124 | 2 | IPR025742 | |
| Domain | CSTF_C | 4.37e-05 | 2 | 124 | 2 | IPR026896 | |
| Domain | SPEC | 5.76e-05 | 32 | 124 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 5.76e-05 | 32 | 124 | 4 | IPR018159 | |
| Domain | RasGAP_C | 1.31e-04 | 3 | 124 | 2 | IPR000593 | |
| Domain | RasGAP_C | 1.31e-04 | 3 | 124 | 2 | PF03836 | |
| Domain | - | 1.41e-04 | 40 | 124 | 4 | 4.10.1000.10 | |
| Domain | ELAD_HUD_SF | 2.60e-04 | 4 | 124 | 2 | IPR006548 | |
| Domain | ZnF_C3H1 | 2.87e-04 | 48 | 124 | 4 | SM00356 | |
| Domain | DUF3504 | 4.32e-04 | 5 | 124 | 2 | IPR021893 | |
| Domain | DUF3504 | 4.32e-04 | 5 | 124 | 2 | PF12012 | |
| Domain | Spectrin | 4.59e-04 | 23 | 124 | 3 | PF00435 | |
| Domain | Znf_CCCH | 5.95e-04 | 58 | 124 | 4 | IPR000571 | |
| Domain | ZF_C3H1 | 5.95e-04 | 58 | 124 | 4 | PS50103 | |
| Domain | Nuc_rcpt_coact | 6.45e-04 | 6 | 124 | 2 | IPR009110 | |
| Domain | fn3 | 7.46e-04 | 162 | 124 | 6 | PF00041 | |
| Domain | Plectin | 8.98e-04 | 7 | 124 | 2 | PF00681 | |
| Domain | Znf_MYM | 8.98e-04 | 7 | 124 | 2 | IPR010507 | |
| Domain | Plectin_repeat | 8.98e-04 | 7 | 124 | 2 | IPR001101 | |
| Domain | zf-FCS | 8.98e-04 | 7 | 124 | 2 | PF06467 | |
| Domain | PLEC | 8.98e-04 | 7 | 124 | 2 | SM00250 | |
| Domain | CH | 9.17e-04 | 65 | 124 | 4 | SM00033 | |
| Domain | TRASH_dom | 1.19e-03 | 8 | 124 | 2 | IPR011017 | |
| Domain | TRASH | 1.19e-03 | 8 | 124 | 2 | SM00746 | |
| Domain | CH | 1.21e-03 | 70 | 124 | 4 | PF00307 | |
| Domain | - | 1.28e-03 | 71 | 124 | 4 | 1.10.418.10 | |
| Domain | CH | 1.41e-03 | 73 | 124 | 4 | PS50021 | |
| Domain | FN3 | 1.48e-03 | 185 | 124 | 6 | SM00060 | |
| Domain | CH-domain | 1.56e-03 | 75 | 124 | 4 | IPR001715 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 2.30e-05 | 51 | 95 | 5 | M665 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 4.04e-05 | 94 | 95 | 6 | M1041 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 8.07e-05 | 13 | 95 | 3 | MM15622 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.06e-04 | 161 | 95 | 7 | M27871 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 1.08e-04 | 37 | 95 | 4 | M29790 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 2.14e-04 | 44 | 95 | 4 | M27295 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 2.77e-04 | 47 | 95 | 4 | M29777 | |
| Pubmed | TET2 SLAIN2 XRN2 MBNL1 ZMYM2 KIF4A XPO1 TUBGCP2 CSDE1 TRIM33 CCNT1 NCOR2 ANLN NCOA1 KMT2A ELAVL1 EP300 CSTF2T ZMYM3 KNL1 | 3.15e-09 | 1103 | 126 | 20 | 34189442 | |
| Pubmed | TET2 ING2 ZMYM2 KIF4A TRIM33 CCNT1 FOXP4 ANLN NCOA1 KMT2A KNL1 | 4.31e-09 | 268 | 126 | 11 | 33640491 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | GRIPAP1 XRN2 TTC28 HIPK1 LRSAM1 ZMYM2 TUBGCP2 TRIM33 NCOR2 PEF1 MRTFB GNAS ZMYM3 KNL1 | 3.25e-08 | 588 | 126 | 14 | 38580884 |
| Pubmed | TET2 TTC28 ZMYM2 GEMIN5 COPG2 NCOR2 MRTFB DST SATB1 CSTF2T ZMYM3 KNL1 | 4.41e-08 | 418 | 126 | 12 | 34709266 | |
| Pubmed | 5.30e-08 | 28 | 126 | 5 | 29365100 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | SOX5 TET2 ZMYM2 TRIM33 NCOR2 FOXP4 SATB1 NCOA1 KMT2A EP300 ZMYM3 | 6.84e-08 | 351 | 126 | 11 | 38297188 |
| Pubmed | XRN2 INTS1 KIF4A GEMIN5 DHX57 COPG2 XPO1 CSDE1 DST NUP133 KMT2A ELAVL1 ZMYM3 AQR | 1.18e-07 | 653 | 126 | 14 | 22586326 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | XRN2 RIOK1 ABCF3 INTS1 KIF4A COPG2 TUBGCP2 NCOR2 ANLN ELAVL1 GNAS AQR KNL1 | 2.15e-07 | 582 | 126 | 13 | 20467437 |
| Pubmed | SOX5 TET2 XRN2 KBTBD6 ING2 MBNL1 ZMYM2 TNRC6C TRIM33 NCOR2 FOXP4 DST SATB1 CSTF2 NCOA1 KMT2A ELAVL1 PAN3 EP300 ZMYM3 | 2.20e-07 | 1429 | 126 | 20 | 35140242 | |
| Pubmed | 4.62e-07 | 5 | 126 | 3 | 14985122 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ABCF3 IQGAP2 ING2 RBL1 HIPK1 ZMYM2 KIF4A TRIM33 NCOR2 FOXP4 RINT1 SATB1 NUP133 EP300 ZMYM3 | 5.40e-07 | 857 | 126 | 15 | 25609649 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 6.90e-07 | 271 | 126 | 9 | 32433965 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SLAIN2 ABCF3 HDX ZMYM2 CSDE1 TRIM33 CCNT1 NCOR2 RINT1 SATB1 ANLN | 7.07e-07 | 444 | 126 | 11 | 34795231 |
| Pubmed | XRN2 RIOK1 TTC28 RBL1 DHX57 CSDE1 ACE2 RINT1 DST SIK2 KMT2A IQGAP3 AQR | 7.46e-07 | 650 | 126 | 13 | 38777146 | |
| Pubmed | XRN2 INTS1 KIF4A GEMIN5 RNF213 XPO1 CSDE1 TRIM33 CCNT1 NCOR2 NUP133 CSTF2 KMT2A EP300 CSTF2T AQR | 8.63e-07 | 1014 | 126 | 16 | 32416067 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SLAIN2 ZMYM2 KIF4A XPO1 TUBGCP2 PPL CSDE1 RINT1 ANLN NUP133 GPC5 GNAS IQGAP3 ZMYM3 AQR KNL1 BEGAIN | 9.92e-07 | 1155 | 126 | 17 | 20360068 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | SLAIN2 RIOK1 RIPK1 COPG2 XPO1 TNRC6C CSDE1 TRIM33 MRTFB SIK2 PEX5 GNAS DMD PAN3 AGAP1 BEGAIN | 1.17e-06 | 1038 | 126 | 16 | 26673895 |
| Pubmed | 1.39e-06 | 151 | 126 | 7 | 17043677 | ||
| Pubmed | 1.45e-06 | 152 | 126 | 7 | 38360978 | ||
| Pubmed | SOX5 ING2 MBNL1 ZNF254 ZMYM2 ZC3H6 CITED2 ZMAT3 SATB1 NCOA1 PLAG1 ZNF91 NFAT5 UTY | 1.49e-06 | 808 | 126 | 14 | 20412781 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | USP53 LRRN1 ERV3-1 MBNL1 RDH10 RNF213 ST3GAL1 TNRC6C STEAP2 SUCLA2 CSDE1 NCOR2 FOXP4 MRTFB GNAS PAN3 NFAT5 EP300 AGAP1 | 1.81e-06 | 1489 | 126 | 19 | 28611215 |
| Pubmed | SLAIN2 INTS1 ZMYM2 KIF4A GEMIN5 DHX57 COPG2 CSDE1 TRIM33 CCNT1 MRTFB DST ANLN KMT2A IQGAP3 CSTF2T ZMYM3 AQR AGAP1 | 1.96e-06 | 1497 | 126 | 19 | 31527615 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.04e-06 | 398 | 126 | 10 | 35016035 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 2.28e-06 | 104 | 126 | 6 | 31240132 | |
| Pubmed | 2.57e-06 | 8 | 126 | 3 | 17475621 | ||
| Pubmed | SLAIN2 TTC28 RBL1 RNF213 TUBGCP2 SLC25A22 TRIM33 CCNT1 NCOR2 FOXP4 PEX5 CEP295 UNC5D EP300 ZMYM3 KNL1 | 2.97e-06 | 1116 | 126 | 16 | 31753913 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | USP53 TET2 SLAIN2 TTC28 EXPH5 KIAA0753 FSIP2 DST ANLN SIK2 KMT2A GNAS PAN3 AQR | 3.11e-06 | 861 | 126 | 14 | 36931259 |
| Pubmed | SLAIN2 GRIPAP1 KRT10 TTC28 IQGAP2 KIF4A RNF213 COPG2 PPL TRIM33 DST PEX5 AGAP1 | 5.26e-06 | 777 | 126 | 13 | 35844135 | |
| Pubmed | SLAIN2 TTC28 KIF4A GEMIN5 CSDE1 MRTFB ANLN CSTF2 KMT2A EP300 CSTF2T | 5.44e-06 | 549 | 126 | 11 | 38280479 | |
| Pubmed | 5.47e-06 | 10 | 126 | 3 | 12738788 | ||
| Pubmed | Natural helix 9 mutants of PPARγ differently affect its transcriptional activity. | 5.47e-06 | 10 | 126 | 3 | 30595551 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | KRT10 IQGAP2 COPG2 XPO1 SUCLA2 CSDE1 CCNT1 NCOR2 CSTF2 ELAVL1 ELAVL4 GNAS | 5.80e-06 | 665 | 126 | 12 | 30457570 |
| Pubmed | 7.50e-06 | 11 | 126 | 3 | 11704662 | ||
| Pubmed | Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. | 7.50e-06 | 11 | 126 | 3 | 15681609 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | MBNL1 INTS1 DHX57 TUBGCP2 CSDE1 PEF1 KRT24 ELAVL1 ELAVL4 PAN3 | 7.58e-06 | 462 | 126 | 10 | 31138677 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | XRN2 ABCF3 LRSAM1 KIF4A GEMIN5 DHX57 XPO1 CSDE1 SLC25A22 CCNT1 NCOR2 DST ANLN NUP133 ELAVL1 ZMYM3 AQR | 8.17e-06 | 1353 | 126 | 17 | 29467282 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | KRT10 XRN2 KALRN INTS1 ZMYM2 DHX57 XPO1 ZC3H6 DST CSTF2 ELAVL1 PAN3 CSTF2T ZMYM3 AQR | 9.24e-06 | 1082 | 126 | 15 | 38697112 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | XRN2 MBNL1 ZMYM2 KIF4A COPG2 TRIM33 CCNT1 NCOR2 PEF1 ANLN CSTF2 KMT2A ELAVL1 KNL1 | 9.95e-06 | 954 | 126 | 14 | 36373674 |
| Pubmed | SOX5 EXPH5 HIPK1 ZMYM2 PPL NCOR2 MRTFB DST SPRED1 PLAG1 KNL1 | 1.08e-05 | 591 | 126 | 11 | 15231748 | |
| Pubmed | A family of splice variants of CstF-64 expressed in vertebrate nervous systems. | 1.30e-05 | 2 | 126 | 2 | 19284619 | |
| Pubmed | Recognition of GU-rich polyadenylation regulatory elements by human CstF-64 protein. | 1.30e-05 | 2 | 126 | 2 | 12773396 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 17029590 | ||
| Pubmed | LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein. | 1.30e-05 | 2 | 126 | 2 | 36735681 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 24486332 | ||
| Pubmed | HuR is necessary for mammary epithelial cell proliferation and polarity at least in part via ΔNp63. | 1.30e-05 | 2 | 126 | 2 | 23028944 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 36228039 | ||
| Pubmed | Characterization of the MLL partner gene AF15q14 involved in t(11;15)(q23;q14). | 1.30e-05 | 2 | 126 | 2 | 12618768 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 36757924 | ||
| Pubmed | Role of Human Antigen R (HuR) in the Regulation of Pulmonary ACE2 Expression. | 1.30e-05 | 2 | 126 | 2 | 35011584 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 21493871 | ||
| Pubmed | Overlapping and distinct functions of CstF64 and CstF64τ in mammalian mRNA 3' processing. | 1.30e-05 | 2 | 126 | 2 | 24149845 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 29073199 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 26018658 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 14681198 | ||
| Pubmed | ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis. | 1.30e-05 | 2 | 126 | 2 | 24695436 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 16207706 | ||
| Pubmed | CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer. | 1.30e-05 | 2 | 126 | 2 | 19904269 | |
| Pubmed | Synergistic effect of human CycT1 and CRM1 on HIV-1 propagation in rat T cells and macrophages. | 1.30e-05 | 2 | 126 | 2 | 19435492 | |
| Pubmed | 1.33e-05 | 83 | 126 | 5 | 28794006 | ||
| Pubmed | SLAIN2 XRN2 MBNL1 DHX57 CSDE1 ZMAT3 PEF1 DST NXF2 ELAVL1 ELAVL4 CSTF2T | 1.34e-05 | 723 | 126 | 12 | 34133714 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | USP53 SLAIN2 GRIPAP1 RIOK1 TTC28 TNRC6C TUBGCP2 CSDE1 RINT1 MRTFB PEX5 CEP295 PAN3 | 1.42e-05 | 853 | 126 | 13 | 28718761 |
| Pubmed | 1.46e-05 | 216 | 126 | 7 | 31519766 | ||
| Pubmed | GRIPAP1 RIOK1 TTC28 KIF4A RNF213 TUBGCP2 PEF1 ANLN CSTF2 PEX5 CEP295 KNL1 | 1.53e-05 | 733 | 126 | 12 | 34672954 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.64e-05 | 220 | 126 | 7 | 35785414 | |
| Pubmed | KRT10 XRN2 ABCF3 INTS1 KIF4A GEMIN5 RNF213 ST3GAL1 XPO1 TUBGCP2 NCOR2 NUP133 ELAVL1 GNAS AQR | 2.26e-05 | 1168 | 126 | 15 | 19946888 | |
| Pubmed | SLAIN2 XRN2 RBL1 HDX ZMYM2 XPO1 CSDE1 SLC25A22 CCNT1 CSTF2 KMT2A DMD CTSG | 2.97e-05 | 916 | 126 | 13 | 32203420 | |
| Pubmed | 3.04e-05 | 17 | 126 | 3 | 19183483 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 3.62e-05 | 341 | 126 | 8 | 32971831 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 27239967 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 25722290 | ||
| Pubmed | A t(11;15) fuses MLL to two different genes, AF15q14 and a novel gene MPFYVE on chromosome 15. | 3.90e-05 | 3 | 126 | 2 | 12618766 | |
| Pubmed | HuR Stabilizes lnc-Sox5 mRNA to Promote Tongue Carcinogenesis. | 3.90e-05 | 3 | 126 | 2 | 28371600 | |
| Pubmed | IκB kinase β (IKKβ) inhibits p63 isoform γ (TAp63γ) transcriptional activity. | 3.90e-05 | 3 | 126 | 2 | 23589370 | |
| Pubmed | Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a. | 3.90e-05 | 3 | 126 | 2 | 11773079 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 26305964 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 30137358 | ||
| Pubmed | Involvement of IQGAP family proteins in the regulation of mammalian cell cytokinesis. | 3.90e-05 | 3 | 126 | 2 | 25229330 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 9751500 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 12646957 | ||
| Pubmed | ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation. | 3.90e-05 | 3 | 126 | 2 | 16024799 | |
| Pubmed | HuB and HuD repress telomerase activity by dissociating HuR from TERC. | 3.90e-05 | 3 | 126 | 2 | 33589924 | |
| Pubmed | Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2. | 3.90e-05 | 3 | 126 | 2 | 12778114 | |
| Pubmed | The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. | 3.90e-05 | 3 | 126 | 2 | 8855229 | |
| Pubmed | SATB1 makes a complex with p300 and represses gp91(phox) promoter activity. | 3.90e-05 | 3 | 126 | 2 | 14605447 | |
| Pubmed | Acetylation of sox2 induces its nuclear export in embryonic stem cells. | 3.90e-05 | 3 | 126 | 2 | 19591226 | |
| Pubmed | p300 functions as a coactivator for the peroxisome proliferator-activated receptor alpha. | 3.90e-05 | 3 | 126 | 2 | 9407140 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 12482985 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 30377250 | ||
| Pubmed | Co-activator SRC-1 is dispensable for transcriptional control by STAT3. | 3.90e-05 | 3 | 126 | 2 | 19203349 | |
| Pubmed | CITED2 mediates the paradoxical responses of HIF-1alpha to proteasome inhibition. | 3.90e-05 | 3 | 126 | 2 | 17906695 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 32168425 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 22493426 | ||
| Pubmed | miR-375 inhibits differentiation of neurites by lowering HuD levels. | 3.90e-05 | 3 | 126 | 2 | 20584986 | |
| Pubmed | SIK2 regulates fasting-induced PPARα activity and ketogenesis through p300. | 3.90e-05 | 3 | 126 | 2 | 26983400 | |
| Pubmed | Homozygous loss-of-function mutations in FSIP2 cause male infertility with asthenoteratospermia. | 3.90e-05 | 3 | 126 | 2 | 30745215 | |
| Pubmed | Expression of CD83 is regulated by HuR via a novel cis-active coding region RNA element. | 3.90e-05 | 3 | 126 | 2 | 16484227 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 16782091 | ||
| Pubmed | The antiobesity factor WDTC1 suppresses adipogenesis via the CRL4WDTC1 E3 ligase. | 4.28e-05 | 453 | 126 | 9 | 27113764 | |
| Pubmed | 5.06e-05 | 20 | 126 | 3 | 12702649 | ||
| Pubmed | 5.06e-05 | 20 | 126 | 3 | 17661632 | ||
| Interaction | SNW1 interactions | GRIPAP1 XRN2 RIOK1 ABCF3 RBL1 INTS1 KIF4A COPG2 TUBGCP2 CSDE1 ACE2 CCNT1 ZMAT3 NCOR2 RINT1 ANLN HECW2 NCOA1 KMT2A ELAVL1 EP300 AQR | 6.92e-10 | 747 | 122 | 22 | int:SNW1 |
| Interaction | SOX7 interactions | 6.54e-07 | 82 | 122 | 7 | int:SOX7 | |
| Interaction | PML interactions | TET2 SLAIN2 ABCF3 HIPK1 HDX ZMYM2 RNF213 CSDE1 SLC25A22 TRIM33 CCNT1 NCOR2 RINT1 SATB1 ANLN TP63 KMT2A EP300 ZMYM3 KNL1 | 7.99e-07 | 933 | 122 | 20 | int:PML |
| Interaction | AR interactions | TET2 XRN2 ING2 RBL1 EXPH5 ZMYM2 KIF4A RNF213 XPO1 TRIM33 CCNT1 NCOR2 FOXP4 ANLN NCOA1 KMT2A ELAVL1 GNAS EP300 KNL1 | 2.05e-06 | 992 | 122 | 20 | int:AR |
| Interaction | SUMO2 interactions | RIOK1 KALRN ZMYM2 KIF4A GEMIN5 RNF213 XPO1 ACE2 TRIM33 ZMAT3 DST ANLN ELAVL1 EP300 ZMYM3 | 2.91e-06 | 591 | 122 | 15 | int:SUMO2 |
| Interaction | FOXP1 interactions | 3.64e-06 | 256 | 122 | 10 | int:FOXP1 | |
| Interaction | FOXP2 interactions | 4.16e-06 | 70 | 122 | 6 | int:FOXP2 | |
| Interaction | KLF8 interactions | SOX5 XRN2 ING2 ZMYM2 XPO1 TRIM33 NCOR2 FOXP4 TP63 EP300 ZMYM3 | 5.20e-06 | 329 | 122 | 11 | int:KLF8 |
| Interaction | BAG2 interactions | RIPK1 EXPH5 MBNL1 COPG2 TUBGCP2 KIAA0753 CSDE1 TRIM33 MRTFB ANLN B3GNT2 SIK2 EP300 CSTF2T KNL1 | 5.41e-06 | 622 | 122 | 15 | int:BAG2 |
| Interaction | TERF2IP interactions | XRN2 ARPP21 KBTBD6 INTS1 ZMYM2 KIF4A XPO1 TRIM33 CCNT1 NCOR2 ANLN KMT2A ZMYM3 KNL1 | 6.44e-06 | 552 | 122 | 14 | int:TERF2IP |
| Interaction | ERG interactions | 8.75e-06 | 223 | 122 | 9 | int:ERG | |
| Interaction | CSDE1 interactions | 9.07e-06 | 284 | 122 | 10 | int:CSDE1 | |
| Interaction | RCOR1 interactions | SOX5 GRIPAP1 TTC28 ZMYM2 GEMIN5 COPG2 NCOR2 MRTFB DST SATB1 CSTF2T ZMYM3 KNL1 | 9.52e-06 | 494 | 122 | 13 | int:RCOR1 |
| Interaction | EGR2 interactions | 9.66e-06 | 171 | 122 | 8 | int:EGR2 | |
| Interaction | HDAC1 interactions | TET2 RIOK1 TTC28 ING2 RBL1 ZMYM2 KIF4A GEMIN5 COPG2 XPO1 NCOR2 MRTFB DST SATB1 ANLN KMT2A EP300 CSTF2T ZMYM3 KNL1 | 1.07e-05 | 1108 | 122 | 20 | int:HDAC1 |
| Interaction | NR6A1 interactions | 1.24e-05 | 24 | 122 | 4 | int:NR6A1 | |
| Interaction | CDC5L interactions | TET2 XRN2 RIOK1 ABCF3 KALRN INTS1 KIF4A COPG2 TUBGCP2 FOXP4 DST ANLN ELAVL1 GNAS EP300 AQR KNL1 | 1.56e-05 | 855 | 122 | 17 | int:CDC5L |
| Interaction | SP7 interactions | 1.64e-05 | 304 | 122 | 10 | int:SP7 | |
| Interaction | CEBPA interactions | TET2 SLAIN2 XRN2 RBL1 MBNL1 ZMYM2 KIF4A XPO1 TUBGCP2 CSDE1 TRIM33 CCNT1 NCOR2 ANLN NCOA1 KMT2A ELAVL1 EP300 CSTF2T ZMYM3 KNL1 | 1.75e-05 | 1245 | 122 | 21 | int:CEBPA |
| Interaction | ZBED3 interactions | 1.77e-05 | 9 | 122 | 3 | int:ZBED3 | |
| Interaction | HDAC2 interactions | TET2 SLAIN2 KRT10 ABCF3 ING2 RBL1 ZMYM2 DHX57 CSDE1 NCOR2 SATB1 TP63 KMT2A ELAVL1 DMD EP300 ZMYM3 | 1.81e-05 | 865 | 122 | 17 | int:HDAC2 |
| Interaction | CPSF6 interactions | XRN2 GEMIN5 XPO1 TRIM33 CCNT1 ANLN TP63 B3GNT2 CSTF2 ELAVL1 EP300 CSTF2T AQR | 1.85e-05 | 526 | 122 | 13 | int:CPSF6 |
| Interaction | FOXI1 interactions | 2.03e-05 | 92 | 122 | 6 | int:FOXI1 | |
| Interaction | CSTF3 interactions | 2.21e-05 | 139 | 122 | 7 | int:CSTF3 | |
| Interaction | TRIM28 interactions | XRN2 RIPK1 IQGAP2 ZNF254 GEMIN5 COPG2 ZNF229 SUCLA2 CSDE1 SLC25A22 ACE2 TRIM33 CCNT1 ANLN B3GNT2 NUP133 SIK2 CSTF2 ELAVL1 ZNF91 ZNF98 IQGAP3 EP300 | 2.28e-05 | 1474 | 122 | 23 | int:TRIM28 |
| Interaction | KLF5 interactions | 2.50e-05 | 195 | 122 | 8 | int:KLF5 | |
| Interaction | NONO interactions | TET2 RIOK1 RNF213 DHX57 XPO1 ANLN TP63 NUP133 CSTF2 KMT2A ELAVL1 EP300 CSTF2T | 2.89e-05 | 549 | 122 | 13 | int:NONO |
| Interaction | FOXP4 interactions | 2.91e-05 | 98 | 122 | 6 | int:FOXP4 | |
| Interaction | ZMAT4 interactions | 3.10e-05 | 30 | 122 | 4 | int:ZMAT4 | |
| Interaction | CTBP1 interactions | MARCHF10 RBL1 ZMYM2 ACE2 NCOR2 SATB1 B3GNT2 SSNA1 KMT2A ELAVL1 EP300 | 3.67e-05 | 406 | 122 | 11 | int:CTBP1 |
| Interaction | DDX3X interactions | TET2 KRT10 RIOK1 GEMIN5 DHX57 XPO1 CSDE1 ACE2 TRIM33 ANLN B3GNT2 NUP133 ELAVL1 EP300 | 4.03e-05 | 651 | 122 | 14 | int:DDX3X |
| Interaction | SERPINB12 interactions | 4.53e-05 | 106 | 122 | 6 | int:SERPINB12 | |
| Interaction | PAN3 interactions | 4.63e-05 | 65 | 122 | 5 | int:PAN3 | |
| Interaction | COL17A1 interactions | 5.15e-05 | 34 | 122 | 4 | int:COL17A1 | |
| Interaction | KDM1A interactions | TET2 GRIPAP1 RIOK1 TTC28 ZMYM2 GEMIN5 COPG2 XPO1 ACE2 NCOR2 MRTFB DST SATB1 EP300 CSTF2T ZMYM3 KNL1 | 5.23e-05 | 941 | 122 | 17 | int:KDM1A |
| Interaction | MYL9 interactions | 5.36e-05 | 67 | 122 | 5 | int:MYL9 | |
| Interaction | RBBP7 interactions | TET2 RIOK1 TTC28 ING2 ZMYM2 PPL NCOR2 ANLN KMT2A EP300 ZMYM3 KNL1 | 5.97e-05 | 507 | 122 | 12 | int:RBBP7 |
| Interaction | IGF2BP1 interactions | SOX5 RIOK1 XPO1 TUBGCP2 CSDE1 ACE2 ANLN TP63 B3GNT2 ELAVL1 ELAVL4 EP300 | 6.09e-05 | 508 | 122 | 12 | int:IGF2BP1 |
| Interaction | ADAR interactions | 6.20e-05 | 286 | 122 | 9 | int:ADAR | |
| Interaction | SUMO1 interactions | 6.36e-05 | 287 | 122 | 9 | int:SUMO1 | |
| Interaction | ARPC4 interactions | 6.61e-05 | 165 | 122 | 7 | int:ARPC4 | |
| Interaction | ASCC1 interactions | 7.08e-05 | 71 | 122 | 5 | int:ASCC1 | |
| Interaction | KLF3 interactions | 7.56e-05 | 228 | 122 | 8 | int:KLF3 | |
| Interaction | PPARD interactions | 7.87e-05 | 117 | 122 | 6 | int:PPARD | |
| Interaction | CDT1 interactions | 8.64e-05 | 74 | 122 | 5 | int:CDT1 | |
| Interaction | SKIL interactions | 8.64e-05 | 119 | 122 | 6 | int:SKIL | |
| Interaction | PDCD6IP interactions | 8.79e-05 | 233 | 122 | 8 | int:PDCD6IP | |
| Interaction | CDC20 interactions | 9.06e-05 | 234 | 122 | 8 | int:CDC20 | |
| Interaction | DUSP16 interactions | 9.89e-05 | 237 | 122 | 8 | int:DUSP16 | |
| Interaction | NFKB1 interactions | 1.06e-04 | 307 | 122 | 9 | int:NFKB1 | |
| Interaction | SIN3A interactions | 1.07e-04 | 380 | 122 | 10 | int:SIN3A | |
| Interaction | USP16 interactions | 1.18e-04 | 79 | 122 | 5 | int:USP16 | |
| Interaction | MKRN2 interactions | 1.19e-04 | 385 | 122 | 10 | int:MKRN2 | |
| Interaction | YTHDF2 interactions | 1.20e-04 | 312 | 122 | 9 | int:YTHDF2 | |
| Interaction | NPAS1 interactions | 1.24e-04 | 245 | 122 | 8 | int:NPAS1 | |
| Interaction | AARD interactions | 1.38e-04 | 17 | 122 | 3 | int:AARD | |
| Interaction | ASF1A interactions | 1.39e-04 | 249 | 122 | 8 | int:ASF1A | |
| Interaction | SMG7 interactions | 1.42e-04 | 319 | 122 | 9 | int:SMG7 | |
| Interaction | CBX3 interactions | ZMYM2 KIF4A XPO1 SLC25A22 TRIM33 ANLN HECW2 KMT2A ELAVL1 ZNF91 EP300 ZMYM3 KNL1 | 1.49e-04 | 646 | 122 | 13 | int:CBX3 |
| Interaction | TRIM24 interactions | SOX5 ZNF254 ZMYM2 XPO1 TNRC6C TRIM33 PEX5 NCOA1 ELAVL1 EP300 | 1.56e-04 | 398 | 122 | 10 | int:TRIM24 |
| Interaction | TRIM52 interactions | 1.59e-04 | 133 | 122 | 6 | int:TRIM52 | |
| Interaction | CRX interactions | 1.59e-04 | 254 | 122 | 8 | int:CRX | |
| Interaction | RUNX1 interactions | 1.60e-04 | 324 | 122 | 9 | int:RUNX1 | |
| Interaction | STH interactions | 1.65e-04 | 18 | 122 | 3 | int:STH | |
| Interaction | SIRT7 interactions | XRN2 INTS1 KIF4A GEMIN5 DHX57 COPG2 XPO1 CSDE1 DST NUP133 KMT2A ELAVL1 ZMYM3 AQR | 1.66e-04 | 744 | 122 | 14 | int:SIRT7 |
| Interaction | SNRPA interactions | RIOK1 MBNL1 GEMIN5 XPO1 ACE2 ANLN TP63 CSTF2 ELAVL1 EP300 AQR | 1.69e-04 | 482 | 122 | 11 | int:SNRPA |
| Interaction | BRCA1 interactions | SLAIN2 XRN2 TTC28 RBL1 GEMIN5 XPO1 TNRC6C CSDE1 TRIM33 DST ANLN TP63 NUP133 CSTF2 PEX5 NCOA1 EP300 ZMYM3 KNL1 | 1.80e-04 | 1249 | 122 | 19 | int:BRCA1 |
| Interaction | GSC interactions | 1.86e-04 | 87 | 122 | 5 | int:GSC | |
| Interaction | SPATA2 interactions | 1.86e-04 | 87 | 122 | 5 | int:SPATA2 | |
| Interaction | TAF15 interactions | TET2 GEMIN5 ACE2 TRIM33 CCNT1 B3GNT2 ELAVL1 EP300 CSTF2T AQR | 1.90e-04 | 408 | 122 | 10 | int:TAF15 |
| Interaction | S100A2 interactions | 2.06e-04 | 412 | 122 | 10 | int:S100A2 | |
| Interaction | CFH interactions | 2.11e-04 | 140 | 122 | 6 | int:CFH | |
| Interaction | ERV3-1 interactions | 2.16e-04 | 4 | 122 | 2 | int:ERV3-1 | |
| Interaction | RDH10 interactions | 2.29e-04 | 20 | 122 | 3 | int:RDH10 | |
| Interaction | FEV interactions | 2.39e-04 | 203 | 122 | 7 | int:FEV | |
| Interaction | STRAP interactions | 2.42e-04 | 270 | 122 | 8 | int:STRAP | |
| Interaction | CYLD interactions | SLAIN2 KRT10 RIPK1 HDX GEMIN5 RNF213 XPO1 TNRC6C FGL2 CSDE1 SLC25A22 TRIM33 FOXP4 MRTFB ELAVL1 | 2.42e-04 | 868 | 122 | 15 | int:CYLD |
| Interaction | WWTR1 interactions | SLAIN2 TTC28 GEMIN5 CSDE1 ANLN TP63 CSTF2 KMT2A EP300 CSTF2T | 2.49e-04 | 422 | 122 | 10 | int:WWTR1 |
| Interaction | MECP2 interactions | KRT10 XRN2 KALRN INTS1 ZMYM2 DHX57 XPO1 ZC3H6 CCNT1 DST ANLN HECW2 CSTF2 ELAVL1 PAN3 EP300 CSTF2T ZMYM3 AQR | 2.64e-04 | 1287 | 122 | 19 | int:MECP2 |
| Interaction | SSRP1 interactions | INTS1 GEMIN5 XPO1 CSDE1 ACE2 TRIM33 ANLN B3GNT2 CSTF2 KMT2A ELAVL1 EP300 AQR | 2.64e-04 | 685 | 122 | 13 | int:SSRP1 |
| Interaction | CPEB1 interactions | 2.64e-04 | 146 | 122 | 6 | int:CPEB1 | |
| Interaction | CTDP1 interactions | 2.69e-04 | 207 | 122 | 7 | int:CTDP1 | |
| Interaction | HNF4A interactions | 2.73e-04 | 275 | 122 | 8 | int:HNF4A | |
| Interaction | HNRNPUL1 interactions | 2.89e-04 | 351 | 122 | 9 | int:HNRNPUL1 | |
| Interaction | AP2M1 interactions | 2.90e-04 | 430 | 122 | 10 | int:AP2M1 | |
| Interaction | RIC8A interactions | 2.95e-04 | 96 | 122 | 5 | int:RIC8A | |
| Interaction | FOXP3 interactions | HIPK1 MBNL1 KIF4A COPG2 TUBGCP2 FOXP4 SATB1 NUP133 NFAT5 EP300 | 3.01e-04 | 432 | 122 | 10 | int:FOXP3 |
| Interaction | CHTOP interactions | 3.11e-04 | 212 | 122 | 7 | int:CHTOP | |
| Interaction | PABPC1 interactions | TET2 RIOK1 XPO1 TNRC6C CSDE1 ACE2 TRIM33 ANLN B3GNT2 CSTF2 ELAVL1 PAN3 EP300 | 3.21e-04 | 699 | 122 | 13 | int:PABPC1 |
| Interaction | HIPK2 interactions | 3.24e-04 | 98 | 122 | 5 | int:HIPK2 | |
| Interaction | DGKZ interactions | 3.40e-04 | 99 | 122 | 5 | int:DGKZ | |
| Interaction | CIITA interactions | 3.43e-04 | 55 | 122 | 4 | int:CIITA | |
| Interaction | YWHAH interactions | USP53 TET2 SLAIN2 TTC28 EXPH5 SPEG XPO1 KIAA0753 DST ANLN SIK2 NCOA1 KMT2A ELAVL1 PAN3 AQR AGAP1 | 3.47e-04 | 1102 | 122 | 17 | int:YWHAH |
| Interaction | CITED2 interactions | 3.51e-04 | 23 | 122 | 3 | int:CITED2 | |
| Interaction | PJA2 interactions | 3.52e-04 | 154 | 122 | 6 | int:PJA2 | |
| Interaction | KRT8 interactions | 3.54e-04 | 441 | 122 | 10 | int:KRT8 | |
| Interaction | ISCA1 interactions | 3.56e-04 | 100 | 122 | 5 | int:ISCA1 | |
| Interaction | PUM1 interactions | 3.64e-04 | 287 | 122 | 8 | int:PUM1 | |
| Interaction | EXPH5 interactions | 3.68e-04 | 56 | 122 | 4 | int:EXPH5 | |
| Interaction | ANXA2P2 interactions | 3.68e-04 | 56 | 122 | 4 | int:ANXA2P2 | |
| GeneFamily | Zinc fingers MYM-type | 3.31e-04 | 6 | 86 | 2 | 86 | |
| GeneFamily | EF-hand domain containing|Plakins | 6.15e-04 | 8 | 86 | 2 | 939 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 8.17e-07 | 155 | 125 | 8 | M39246 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 4.36e-06 | 137 | 125 | 7 | M39241 | |
| Coexpression | GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN | 2.16e-05 | 175 | 125 | 7 | M2940 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 2.32e-05 | 177 | 125 | 7 | M39245 | |
| Coexpression | GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP | 2.68e-05 | 181 | 125 | 7 | M6849 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 3.72e-08 | 176 | 125 | 8 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 3.89e-08 | 177 | 125 | 8 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 5.95e-08 | 187 | 125 | 8 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 8.55e-08 | 196 | 125 | 8 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.12e-06 | 190 | 125 | 7 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 195 | 125 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 195 | 125 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.38e-06 | 196 | 125 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | critical-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.38e-06 | 196 | 125 | 7 | dbf14f5851c2b779a8b35e820c4584ea9096e49d | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.48e-06 | 198 | 125 | 7 | e36303628af3139310c1d7a84d2919b7319bbda4 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.48e-06 | 198 | 125 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.53e-06 | 199 | 125 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.04e-06 | 149 | 125 | 6 | f53151d9e5e724a61be0ee6a8c740d1990f28d5f | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.04e-06 | 149 | 125 | 6 | 9286bc56ff2e245630537a0bda5f1a1e17be863a | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.46e-06 | 157 | 125 | 6 | 74038192f016f95f80e0189035ee8ccc22ceb1b8 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F-|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.46e-06 | 157 | 125 | 6 | 982e6ea78c7dabdb7c07c4a5fb2425d5e45b5b94 | |
| ToppCell | Posterior_cortex|World / BrainAtlas - Mouse McCarroll V32 | 5.88e-06 | 159 | 125 | 6 | 18e9fe2efbe0bca7c3990f3b12b6f549e2c1263a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.91e-06 | 171 | 125 | 6 | 55c7bf7211587fa08df13c0a4ff5b78a85d5439e | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_Myeloid|bone_marrow / Manually curated celltypes from each tissue | 9.52e-06 | 173 | 125 | 6 | 5645a3b1e805c71d5d65fc8e4edc4e13208063fc | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_2|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.84e-06 | 174 | 125 | 6 | a75ba49ccea6bd3d78ada1092b46deb5202c58a5 | |
| ToppCell | Dividing_Macrophages-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.02e-05 | 175 | 125 | 6 | 0a8bf455babb3271aa00642199fb58b0b02dc3ac | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-05 | 177 | 125 | 6 | 8dfadd9852e0c256363471a7cfe6af120c8c51e0 | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-05 | 177 | 125 | 6 | 767b2af5f224d100b22bed32f86cec1cd17e8711 | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-05 | 177 | 125 | 6 | 5ef2527e9b41e62f1724cdabaad9d8979266bb7d | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-05 | 177 | 125 | 6 | ae1d2fdd4f67f50c906b27ea084de058c6908aa2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-05 | 179 | 125 | 6 | d1ef7e1cb00336118e387b47f4f8120f53584391 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 184 | 125 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|lymph-node_spleen / Manually curated celltypes from each tissue | 1.35e-05 | 184 | 125 | 6 | f93373fcde5c31f4ffe67ca0f3ea7f4e906dc88b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 184 | 125 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.35e-05 | 184 | 125 | 6 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 184 | 125 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19_Convalescent-PLT_4|World / Disease Group and Platelet Clusters | 1.44e-05 | 186 | 125 | 6 | 5954a1e3ffafb33f2a9bc87af3343f304fda4c92 | |
| ToppCell | COVID-19-Heart-Fib_+_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.62e-05 | 112 | 125 | 5 | d00ee6b19e41a35450681fe676885983536d6292 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-05 | 191 | 125 | 6 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 1.67e-05 | 191 | 125 | 6 | a3c5a913a99f17633c140ec9ece81b73e59e0715 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.77e-05 | 193 | 125 | 6 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.77e-05 | 193 | 125 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.77e-05 | 193 | 125 | 6 | 33349830e9eba506470ad3661fad5e5a283d20ca | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 1.88e-05 | 195 | 125 | 6 | 578bbb06a5476c08fc3b351cc580c551dfe53ae4 | |
| ToppCell | NS-critical-LOC-Lymphoid-CTL|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.04e-05 | 198 | 125 | 6 | e2acb074142aa62c763139bbcf36f6f85038d04b | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.04e-05 | 198 | 125 | 6 | 844f534551483c89ef789d1cfeb4680e54f794b2 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-05 | 198 | 125 | 6 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-granulocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.04e-05 | 198 | 125 | 6 | 2e669da80363163b806f23a645474d482797ae5d | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 2.04e-05 | 198 | 125 | 6 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Late_airway_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.10e-05 | 199 | 125 | 6 | 494461665f945ce6c97299c58f7785e90dec5812 | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.10e-05 | 199 | 125 | 6 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 2.16e-05 | 200 | 125 | 6 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD8+_T_naive|Control / Disease, condition lineage and cell class | 2.16e-05 | 200 | 125 | 6 | 906de95adc9716982ab32f216dddeb52639bad06 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.16e-05 | 200 | 125 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.83e-05 | 134 | 125 | 5 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.03e-05 | 68 | 125 | 4 | f1cbc6d72489272c1eb6200f64b8b6444719acda | |
| ToppCell | Dividing_Macrophages-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 6.15e-05 | 148 | 125 | 5 | 66b51aa6690bf8fbc90fa5a6f86191703e2d5046 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 155 | 125 | 5 | 0e942609d3e060f1e589fee5997fc6299f3d18bc | |
| ToppCell | 3'_v3-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Lung / Manually curated celltypes from each tissue | 9.70e-05 | 163 | 125 | 5 | 47300dec94dc66e965bf71fafff0a9fd24fae968 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.98e-05 | 164 | 125 | 5 | 0662cd9d21608efacc336e0a582859f3b9a4951d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.98e-05 | 164 | 125 | 5 | 1642a67c66eeb77a218e7814e3cfe517d9822955 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.98e-05 | 164 | 125 | 5 | 25758fb8112baf296264122d5d4121f1ebb3d0fa | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 165 | 125 | 5 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| ToppCell | Dividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.06e-04 | 166 | 125 | 5 | c503036f3c19ef186e1e62c9643c49dea3827f51 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 167 | 125 | 5 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | 10x5'-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Lung / Manually curated celltypes from each tissue | 1.09e-04 | 167 | 125 | 5 | 82739226347d74897be000f429b73543a031af96 | |
| ToppCell | 10x5'-Lung-Hematopoietic_progenitors|Lung / Manually curated celltypes from each tissue | 1.09e-04 | 167 | 125 | 5 | dec18caf0475002d4ad3c7bc7fc3050cbc8e6bae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 167 | 125 | 5 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-04 | 168 | 125 | 5 | b7cd33f5da4f37b9384fc3bd3ca01fbc790accfc | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 168 | 125 | 5 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 169 | 125 | 5 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | Dividing_Macrophages-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.15e-04 | 169 | 125 | 5 | bc859a103cad567caf50c3c3882d2d2017807c73 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 169 | 125 | 5 | 54b13ab02b4c187f4754045ecfcf409749e7ccc0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 171 | 125 | 5 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.21e-04 | 171 | 125 | 5 | 13126a3fbee181412c13ffb0c347277b9d8f16f7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 171 | 125 | 5 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-04 | 172 | 125 | 5 | c06ca5d075937747952ed915c9db39a9f62072f9 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 173 | 125 | 5 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l44|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.28e-04 | 173 | 125 | 5 | b6bb2a136a40f0946bbcde8d5972d3f059d080c7 | |
| ToppCell | CV-Mild-7|Mild / Virus stimulation, Condition and Cluster | 1.28e-04 | 173 | 125 | 5 | c9bbca9313a0fdf146c8c995624b94b937e818d8 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 173 | 125 | 5 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 173 | 125 | 5 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.32e-04 | 174 | 125 | 5 | c988471207ba06195bc3e41056435e8c31c20bbe | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 174 | 125 | 5 | c26eac176e9b0cba385630fdc60e0314a4e4caac | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.35e-04 | 175 | 125 | 5 | cc596907ea1a64ab7b5a8c7d4ad12e6ee59bfed9 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.35e-04 | 175 | 125 | 5 | a8400e7e47379901dcab5f2e364c3ff17765b4b9 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Promonocyte-like|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.35e-04 | 175 | 125 | 5 | 654299df246debe0a5b12f0d9568eb828bb94bb9 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 175 | 125 | 5 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 175 | 125 | 5 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.35e-04 | 175 | 125 | 5 | 8a3abf40146ae3459d97cdf865c1c8f6b92ac639 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 175 | 125 | 5 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.35e-04 | 175 | 125 | 5 | 378d2b79edac91fc74eee0fb42bb29dd9b07c36f | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 177 | 125 | 5 | 8a0f0fbb06cdacb99a3fdba0da3e0494b891db4f | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 177 | 125 | 5 | e9d7682517fb30fd2ad535d59779d718a7024c13 | |
| ToppCell | facs-Brain_Myeloid-Striatum|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 177 | 125 | 5 | efb1990fd1d216f64261e81017299783afb24a1e | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.43e-04 | 177 | 125 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 180 | 125 | 5 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.58e-04 | 181 | 125 | 5 | cfc3ed541d93158ce26641ea30b7573d93600a11 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-04 | 181 | 125 | 5 | 40df0afcb6848202da54670e84f22d7c3a515d01 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-04 | 181 | 125 | 5 | 2b53a65ca5616a7b9f64232c3e0b7212d1e2f063 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-04 | 181 | 125 | 5 | 6aef84616e8d2faf54b7e9e6cd02f33c3066dabc | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-04 | 181 | 125 | 5 | 40d3829ae4aaf81e8616c3499ff8933137fc1cc4 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 182 | 125 | 5 | bc6a120dedc813c58baac1428c39851a07b71ba7 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-04 | 182 | 125 | 5 | 4a85429d365c4b2d73fc921f261b4b7635ac40bd | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-04 | 182 | 125 | 5 | 53213af34af3337f5edc734d3b7b79e4349eac0d | |
| Disease | Cafe-au-Lait Spots | 5.07e-05 | 3 | 122 | 2 | C0221263 | |
| Disease | Epidermolysis Bullosa Simplex | 1.68e-04 | 5 | 122 | 2 | C0079298 | |
| Disease | prostate carcinoma | TET2 TTC28 EXPH5 MBNL1 RNF213 PPL FOXP4 ANLN SIK2 PLAG1 GPC5 KNL1 | 3.32e-04 | 891 | 122 | 12 | EFO_0001663 |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 3.51e-04 | 7 | 122 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | Lymphoid leukemia | 4.67e-04 | 8 | 122 | 2 | C0023448 | |
| Disease | mean corpuscular hemoglobin concentration | SOX5 XRN2 TTC28 IQGAP2 KALRN RBL1 LRSAM1 TRIM33 ZMAT3 HECW2 B3GNT2 PAN3 AGAP1 | 6.70e-04 | 1105 | 122 | 13 | EFO_0004528 |
| Disease | age at menarche | 8.32e-04 | 594 | 122 | 9 | EFO_0004703 | |
| Disease | sodium measurement | 8.97e-04 | 103 | 122 | 4 | EFO_0009282 | |
| Disease | autism | 1.04e-03 | 48 | 122 | 3 | EFO_0003758 | |
| Disease | vitamin supplement exposure measurement, cleft lip | 1.09e-03 | 12 | 122 | 2 | EFO_0003959, EFO_0009116 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 1.99e-03 | 60 | 122 | 3 | C4722327 | |
| Disease | neuroticism measurement, cognitive function measurement | 2.49e-03 | 566 | 122 | 8 | EFO_0007660, EFO_0008354 | |
| Disease | total blood protein measurement | 2.70e-03 | 449 | 122 | 7 | EFO_0004536 | |
| Disease | Vertigo | 2.70e-03 | 139 | 122 | 4 | HP_0002321 | |
| Disease | Prostate cancer, familial | 2.96e-03 | 69 | 122 | 3 | C2931456 | |
| Disease | muscular dystrophy (implicated_via_orthology) | 3.38e-03 | 21 | 122 | 2 | DOID:9884 (implicated_via_orthology) | |
| Disease | chronotype measurement | 3.68e-03 | 882 | 122 | 10 | EFO_0008328 | |
| Disease | sensory peripheral neuropathy, remission | 4.05e-03 | 23 | 122 | 2 | EFO_0009785, MONDO_0002321 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QRMNGRYNFKIQSNN | 1296 | Q5DID0 | |
| LAQQATKMRNVIYQN | 536 | Q14264 | |
| SLQAYQQRLLQQQMG | 2256 | Q09472 | |
| MNYQQQLANSAAIRA | 1 | Q9UPQ3 | |
| DQVNIDYLMNRPQNL | 161 | Q5JQC9 | |
| QSNYMALQRINQELE | 61 | Q9BUH8 | |
| RQLYRLDMSNNNLSN | 271 | Q9NZU0 | |
| QRMYNTLRLAEPQSQ | 66 | Q9NUQ8 | |
| QNAQTMAYNITPLRR | 661 | O75534 | |
| TNLIVNYLPQNMTQE | 51 | P26378 | |
| RVFLDPNQYQQDMTN | 626 | O60306 | |
| SYRQQAANLLQDMGQ | 36 | O60563 | |
| NIIAFYNQLQQLEQM | 831 | P11532 | |
| QEARNMLLQNPQLAY | 156 | P33240 | |
| QYNAQRSQQMPQAAQ | 661 | Q9UBL0 | |
| RYNNMLKQLSSQQLA | 1756 | Q6ZS30 | |
| NSIQQMEQLNRRYQS | 851 | Q9P2P5 | |
| NRQTIINDYITSQQM | 1681 | Q9Y618 | |
| NQSRLQRYMTQFADQ | 881 | Q8WUM0 | |
| QLLNNMRSQYEQLAE | 316 | P13645 | |
| NIRDMSDNVLYQNRN | 356 | Q7Z353 | |
| IFNELSSARNPNNMQ | 446 | Q8N201 | |
| LIQMAYESQRQNLVQ | 401 | Q6UWE0 | |
| RYQIAARQDMQQFLQ | 76 | P78333 | |
| NQYSTIMQQPSLLTN | 801 | Q86Z02 | |
| QKSLNMISSNPQVQY | 2296 | Q03001 | |
| NSKNTLYLQMNNLRA | 91 | A0A0C4DH36 | |
| EINMQQTVIYQASQA | 726 | Q9NQW6 | |
| VYTNMQQNLLQNCLQ | 486 | Q5CZC0 | |
| SLQYLNLRGNMVANL | 246 | Q53EV4 | |
| QARQQHLSSLQDYMQ | 206 | O60437 | |
| MQQIEQSNFRQAPQR | 91 | P50542 | |
| LQNQQNGQRVYTSMS | 36 | Q9H936 | |
| LAVNQQNMCLVYQPA | 2351 | O60229 | |
| MDSNYARLLQQQQLF | 311 | Q9ULH7 | |
| NGNLSNMYEVLNNNE | 321 | Q8N8Q9 | |
| KQTMQNLNDRLANYL | 141 | Q2M2I5 | |
| LNMERNNRYQPLQNH | 321 | Q9UN81 | |
| YPATLRTQIQQMNRQ | 641 | P09848 | |
| QNVYQRVSLNAPMEN | 421 | Q8NEV8 | |
| PNYNLMNIDINNNEL | 2251 | Q8NG31 | |
| TLRQRMLNFVQNIQY | 681 | Q9BSJ2 | |
| LQQQQALMLQQLQEY | 131 | Q8IVH2 | |
| NLIVNYLPQNMTQDE | 21 | Q15717 | |
| TSINQQDMQQSPLYS | 1386 | O94916 | |
| MLGQQQQQLYSSAAL | 1 | Q9H160 | |
| SMYQLELAVLQQQQG | 416 | Q86VI3 | |
| LQQALSQMGYNLSPQ | 206 | Q9UBV8 | |
| QNNNPLALMAQYQQA | 671 | Q58A45 | |
| MQNQSSQLYAALPER | 201 | P49895 | |
| YTNLGLLNSMDQQIQ | 111 | Q9H3D4 | |
| MNTLLIQDIYQQQRA | 396 | Q8WWN9 | |
| NRFNQMLNQIPNDYQ | 2921 | Q99715 | |
| MLNQIPNDYQSSRNQ | 2926 | Q99715 | |
| KMLYEQLQSNSLFNN | 861 | Q6P158 | |
| QSTLAQMYPLQEIQN | 76 | Q9BYF1 | |
| YLNVLQQRQMALNAT | 531 | Q9UBF2 | |
| QQRQMALNATYIFNG | 536 | Q9UBF2 | |
| EPQNQQILQMSYQDI | 446 | Q96JA4 | |
| GIFQYQQALANMQLQ | 316 | Q9NR56 | |
| QSQAQNELMNSGLYL | 736 | Q8NA82 | |
| LNLVNMNNIENYVDS | 161 | Q14314 | |
| RKMTQNDSQLQPIQY | 541 | O95239 | |
| NNYQNLPVQDRNLML | 2586 | Q03164 | |
| RHPQYNQRTIQNDIM | 96 | P08311 | |
| QEARNMLLQNPQLAY | 156 | Q9H0L4 | |
| QRMQAQLLELRTNNY | 11 | Q4V328 | |
| QNYRALQPLNQRMVF | 261 | Q9ULX7 | |
| QMIRNYQHQLLQQNR | 576 | Q9C0D2 | |
| QMNNIPLVSETNNYR | 546 | Q86V97 | |
| SLMLNNNALNAIYQK | 341 | Q6UXK5 | |
| MNKRYNVSQQALDLQ | 221 | Q9GZY0 | |
| YLMALSLQQEQQSQE | 516 | Q8NBR6 | |
| AMNAQQDNILYQTVT | 456 | Q9BRS2 | |
| QQQNQPMDALQAYIC | 326 | O14607 | |
| MTQQGAALQNYNNEL | 1 | O43805 | |
| LAQLRLQHMQQQVYA | 511 | Q9UPN9 | |
| QLQLAYQRLQIQQQM | 1156 | Q9HCJ0 | |
| YQRLQIQQQMLQAQR | 1161 | Q9HCJ0 | |
| QESNYENLSQMNPRS | 306 | Q6ZMC9 | |
| QTMSALKRQNLYNNP | 176 | Q9P270 | |
| LKRQNLYNNPFNSMS | 181 | Q9P270 | |
| FRMLANLQNISLQNN | 361 | Q8TF66 | |
| FQEIMKSYRNQPQAN | 861 | P28749 | |
| AAMYQNELFNLQKQN | 341 | Q13576 | |
| AQMLAQRQRELYSQQ | 1106 | Q15788 | |
| MLVNIQAQNRSITYS | 81 | Q8NG99 | |
| MLVNIQAQAQSINYT | 81 | Q8NG95 | |
| PYNNSQRLLNVIDMA | 386 | Q96MK3 | |
| YNMVIREDNQTNRLQ | 896 | Q5JWF2 | |
| ERFNQTMQPLLTAQN | 76 | Q11201 | |
| KQSQLQAYFNQMQIA | 726 | Q9H0K1 | |
| VSNNMRINQYPESNA | 116 | Q8NFT2 | |
| MTREQYILATQQNNL | 1 | Q96LD1 | |
| QAARSARMLYVLQQQ | 261 | Q2KHM9 | |
| MDRQTKQQPRQNVAY | 391 | Q13546 | |
| MYPFIAQRKQATNNN | 321 | Q8IZV5 | |
| QQQQQRNLSLHEYMS | 46 | Q9P2R7 | |
| TNAMQVINNYQRRCK | 51 | P10153 | |
| LVMAQLLNQQYAVNR | 321 | Q01826 | |
| LNRQYNPILSMLTNQ | 66 | Q9NY97 | |
| PASMQLQKLNNQYFN | 111 | Q99967 | |
| NVSNQQYGQILQMTR | 351 | Q15846 | |
| TAPLIQQQNIMDQCY | 876 | Q70EK8 | |
| LQLNLYNTPFQSMQS | 286 | Q6DJT9 | |
| DPNMQLNVYTQDILQ | 5041 | Q63HN8 | |
| QMLPLNTNIRLAYSN | 296 | O14980 | |
| EMQLNTNYESLQNPA | 581 | P61129 | |
| NDRTTLMNIRNYNVA | 1801 | Q15772 | |
| LSDNIQQYLMTNNVP | 171 | Q6NUQ1 | |
| QLRPNYQLNSSRNML | 441 | Q6ZQQ2 | |
| LNARRVYMQSQANQI | 181 | Q7Z699 | |
| NPRQAAYEMRMQNNS | 456 | Q9H0D6 | |
| MLQTQNAAFQPNQYQ | 896 | Q9H0D6 | |
| EMQQQAQELLQKYGN | 1481 | Q8TEQ6 | |
| QVNLRTSQISTMQQY | 111 | Q96A28 | |
| QEIMQIQQPSQNLEY | 236 | Q8IYU4 | |
| QMLAQKNSINRNLSY | 876 | Q6UXZ4 | |
| RQLYQDVMQENFRNL | 56 | Q9UJW7 | |
| QNLNQRMDVFYLQPE | 1316 | Q9UBW7 | |
| DTAQQNLYRNVMLEN | 31 | Q05481 | |
| YFEQQLAMLQQLSGN | 856 | Q96AY4 | |
| KSLQRIQNGQRNAMY | 1751 | Q96AY4 | |
| DTAQQNLYRNVMLEN | 31 | A6NK75 | |
| MPNRRNMYTVQNNSA | 206 | Q9HA38 | |
| LQLQQLYAAQLAAMQ | 336 | P35711 | |
| ALRQQMQTQNLSAYI | 56 | O43895 | |
| MSGQQAAQLAQQRYL | 906 | Q6N021 | |
| FGENNNINSQINMYL | 116 | Q9Y6I8 | |
| NYQDNISSMNISIQN | 431 | Q8NA31 | |
| GIQQYLLENNRMVNI | 1141 | Q14202 | |
| DIAQQNLYRNVMLEN | 31 | O75437 | |
| ARQYQAMRQRTVQLQ | 826 | Q6PIF6 |